GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for ...

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

Investing.com -- GSK plc (LSE:GSK) announced Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the indication of its RSV ...

The Non-Opioid Therapeutics Market is rapidly expanding due to increased demand for safer pain management Non-Opioid Therapeutics Market Non-Opioid Therapeutics Market Dublin, Dec. 11, 2025 (GLOBE ...

Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...

The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GlaxoSmithKline (GSK) announced the purchase of 250,000 of its own ordinary ...